Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vancomycin and the "red man's syndrome".

Literature DB >> 3155563

Vancomycin and the "red man's syndrome".

J C Garrelts, J D Peterie.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Vancomycin

Year: 1985 PMID： 3155563

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Severe local vancomycin induced skin necrosis.

Authors: Dianne W M Hoelen; David H T Tjan; Roel van Vugt; Y Geert van der Meer; Arthur R H van Zanten
Journal: Br J Clin Pharmacol Date: 2007-04-10 Impact factor: 4.335

2. Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements.

Authors: M C Nahata; P Fan-Havard; W J Barson; H M Bartkowski; E J Kosnik
Journal: Eur J Clin Pharmacol Date: 1990 Impact factor: 2.953

3. Red man syndrome associated with amphotericin B.

Authors: M E Ellis; W Tharpe
Journal: BMJ Date: 1990-06-02

Review 4. Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations.

Authors: E Keller; P Reetze; P Schollmeyer
Journal: Clin Pharmacokinet Date: 1990-02 Impact factor: 6.447

5. Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers.

Authors: M Boeckh; H Lode; K Borner; G Höffken; J Wagner; P Koeppe
Journal: Antimicrob Agents Chemother Date: 1988-01 Impact factor: 5.191

Vancomycin and the "red man's syndrome".

1. Severe local vancomycin induced skin necrosis.

2. Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements.

3. Red man syndrome associated with amphotericin B.

Review 4. Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations.

5. Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers.

6. Potentiation of vancomycin-induced histamine release by muscle relaxants and morphine in rats.

7. Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions.

Review 8. Clinical pharmacokinetics of vancomycin.

9. Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.

10. Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.